Projected Income Statement: Medtronic plc

Forecast Balance Sheet: Medtronic plc

Fiscal Period: April 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 22,796 20,400 22,821 23,740 26,298 22,660 20,621 18,149
Change - -10.51% 11.87% 4.03% 10.78% -13.83% -9% -11.99%
Announcement Date 27/05/21 26/05/22 25/05/23 23/05/24 21/05/25 - - -
1USD in Million
Estimates

Cash Flow Forecast: Medtronic plc

Fiscal Period: April 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 1,355 1,368 1,459 1,587 1,859 1,876 1,951 2,021
Change - 0.96% 6.65% 8.77% 17.14% 0.93% 4.01% 3.55%
Free Cash Flow (FCF) 1 4,885 5,978 4,580 5,200 5,185 5,833 6,614 7,266
Change - 22.37% -23.39% 13.54% -0.29% 12.49% 13.39% 9.87%
Announcement Date 27/05/21 26/05/22 25/05/23 23/05/24 21/05/25 - - -
1USD in Million
Estimates

Forecast Financial Ratios: Medtronic plc

Fiscal Period: April 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 26.88% 31.02% 29.76% 28.51% 28.93% 28.37% 28.98% 29.64%
EBIT Margin (%) 23.83% 27.95% 26.56% 25.56% 25.79% 25.1% 25.67% 25.9%
EBT Margin (%) 12.93% 17.41% 17.18% 14.95% 16.78% 18.25% 20% 20.98%
Net margin (%) 11.97% 15.9% 12.03% 11.36% 13.9% 14.96% 15.84% 16.38%
FCF margin (%) 16.22% 18.87% 14.67% 16.07% 15.46% 16.18% 17.34% 18.11%
FCF / Net Income (%) 135.47% 118.63% 121.87% 141.46% 111.22% 108.1% 109.46% 110.54%

Profitability

        
ROA 6.54% 5.48% 7.74% 7.65% 7.79% 6.78% 7.38% 7.75%
ROE 11.76% 14.44% 13.54% 13.61% 14.41% 15.05% 15.85% 16.32%

Financial Health

        
Leverage (Debt/EBITDA) 2.82x 2.08x 2.46x 2.57x 2.71x 2.22x 1.87x 1.53x
Debt / Free cash flow 4.67x 3.41x 4.98x 4.57x 5.07x 3.89x 3.12x 2.5x

Capital Intensity

        
CAPEX / Current Assets (%) 4.5% 4.32% 4.67% 4.9% 5.54% 5.2% 5.12% 5.04%
CAPEX / EBITDA (%) 16.74% 13.92% 15.7% 17.2% 19.16% 18.34% 17.66% 16.99%
CAPEX / FCF (%) 27.74% 22.88% 31.86% 30.52% 35.85% 32.17% 29.51% 27.81%

Items per share

        
Cash flow per share 1 4.609 5.436 4.531 5.102 5.461 6.375 7.468 8.295
Change - 17.95% -16.64% 12.6% 7.03% 16.74% 17.14% 11.08%
Dividend per Share 1 2.32 2.72 2.72 2.8 2.8 2.844 2.966 3.063
Change - 17.24% 0% 2.94% 0% 1.56% 4.31% 3.25%
Book Value Per Share 1 38.23 39.49 38.69 38.29 36.62 38.16 39.73 41.68
Change - 3.31% -2.04% -1.02% -4.36% 4.19% 4.13% 4.9%
EPS 1 2.66 3.73 2.82 2.76 3.61 4.342 4.736 5.19
Change - 40.23% -24.4% -2.13% 30.8% 20.29% 9.06% 9.59%
Nbr of stocks (in thousands) 13,48,073 13,41,539 13,30,424 13,27,823 12,82,544 12,82,014 12,82,014 12,82,014
Announcement Date 27/05/21 26/05/22 25/05/23 23/05/24 21/05/25 - - -
1USD
Estimates
2026 *2027 *
P/E ratio 23.5x 21.5x
PBR 2.67x 2.57x
EV / Sales 4.25x 3.97x
Yield 2.79% 2.91%
More valuation ratios * Estimated data

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
BBB
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
101.99USD
Average target price
111.05USD
Spread / Average Target
+8.88%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. MDT Stock
  4. Financials Medtronic plc